Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients ...
Fourth quarter revenues increased 116% to $91.1 million versus fourth quarter of 2023Full year revenues increased 473% to $290.5 million versus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback